Theriva Biologics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Theriva Biologics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2023.
  • Theriva Biologics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$55K, a 96% increase year-over-year.
  • Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $625K.
  • Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.93M, a 103% decline from 2021.
  • Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $74M, a 2103% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$55K +$1.32M +96% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 -$1.38M -$75.4M -102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $74M +$74M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 $0 -$435K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $435K +$435K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 $0 -$4K -100% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q1 2014 $4K -$227K -98.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $231K -$1.31M -85% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 $1.54M -$2.17M -58.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $3.71M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.